André Kunert

499 total citations
12 papers, 400 citations indexed

About

André Kunert is a scholar working on Oncology, Immunology and Genetics. According to data from OpenAlex, André Kunert has authored 12 papers receiving a total of 400 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 11 papers in Immunology and 2 papers in Genetics. Recurrent topics in André Kunert's work include Immunotherapy and Immune Responses (9 papers), CAR-T cell therapy research (8 papers) and Cancer Immunotherapy and Biomarkers (7 papers). André Kunert is often cited by papers focused on Immunotherapy and Immune Responses (9 papers), CAR-T cell therapy research (8 papers) and Cancer Immunotherapy and Biomarkers (7 papers). André Kunert collaborates with scholars based in Netherlands, Germany and Belgium. André Kunert's co-authors include Reno Debets, C. B. H. W. Lamers, Stefan Sleijfer, Joachim G.J.V. Aerts, Ron H.J. Mathijssen, Rebecca Wijers, Hinrich Abken, Markus Chmielewski, Cor Berrevoets and Pauline L. de Goeje and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and Clinical Cancer Research.

In The Last Decade

André Kunert

12 papers receiving 394 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
André Kunert Netherlands	10	317	218	88	63	59	12	400
Jiage Ding China	11	300 0.9×	227 1.0×	128 1.5×	44 0.7×	50 0.8×	18	414
Xiaoli Tian China	11	199 0.6×	117 0.5×	107 1.2×	35 0.6×	51 0.9×	15	316
Irina Ganeeva Russia	9	216 0.7×	132 0.6×	130 1.5×	56 0.9×	27 0.5×	16	344
Aleksei Titov Russia	7	214 0.7×	147 0.7×	122 1.4×	70 1.1×	21 0.4×	13	368
Ronan Thibaut France	6	237 0.7×	195 0.9×	137 1.6×	46 0.7×	25 0.4×	7	428
Donghua Shi China	5	254 0.8×	158 0.7×	68 0.8×	42 0.7×	20 0.3×	7	353
Aodrenn Spill Switzerland	4	241 0.8×	137 0.6×	78 0.9×	46 0.7×	19 0.3×	6	300
Daijing Yuan China	7	314 1.0×	149 0.7×	114 1.3×	39 0.6×	21 0.4×	10	402
Daniela Tantalo Australia	6	264 0.8×	133 0.6×	82 0.9×	84 1.3×	18 0.3×	11	304
Caitlin Stashwick United States	10	295 0.9×	153 0.7×	72 0.8×	76 1.2×	26 0.4×	12	368

Countries citing papers authored by André Kunert

Since Specialization

Citations

This map shows the geographic impact of André Kunert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by André Kunert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites André Kunert more than expected).

Fields of papers citing papers by André Kunert

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by André Kunert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by André Kunert. The network helps show where André Kunert may publish in the future.

Co-authorship network of co-authors of André Kunert

This figure shows the co-authorship network connecting the top 25 collaborators of André Kunert. A scholar is included among the top collaborators of André Kunert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with André Kunert. André Kunert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Romero, Pedro, et al.. (2023). 272 PD-L1 CAR engineered K-NK cells to target PD-L1⁺ or PD-L1^- tumors. SHILAP Revista de lepidopterología. A312–A312. 1 indexed citations

Kunert, André, Edwin A. Basak, Daan P. Hurkmans, et al.. (2019). CD45RA+CCR7− CD8 T cells lacking co-stimulatory receptors demonstrate enhanced frequency in peripheral blood of NSCLC patients responding to nivolumab. Journal for ImmunoTherapy of Cancer. 7(1). 149–149. 43 indexed citations

Goeje, Pauline L. de, Koen Bezemer, Margaretha E.H. Kaijen-Lambers, et al.. (2019). Induction of Peripheral Effector CD8 T-cell Proliferation by Combination of Paclitaxel, Carboplatin, and Bevacizumab in Non–small Cell Lung Cancer Patients. Clinical Cancer Research. 25(7). 2219–2227. 40 indexed citations

Dumoulin, Daphne W., Koen Bezemer, Harry J.M. Groen, et al.. (2019). Paclitaxel/ carboplatin/ bevacizumab in non-small cell lung cancer patients induces peripheral effector CD8 T cell proliferation that could be prone for treatment with checkpoint inhibitors. Annals of Oncology. 30. ii7–ii7. 3 indexed citations

Goeje, Pauline L. de, Yarne Klaver, Margaretha E.H. Kaijen-Lambers, et al.. (2018). Autologous Dendritic Cell Therapy in Mesothelioma Patients Enhances Frequencies of Peripheral CD4 T Cells Expressing HLA-DR, PD-1, or ICOS. Frontiers in Immunology. 9. 2034–2034. 11 indexed citations

Kunert, André & Reno Debets. (2018). Engineering T cells for adoptive therapy: outsmarting the tumor. Current Opinion in Immunology. 51. 133–139. 12 indexed citations

Aerts, Joachim G.J.V., Pauline L. de Goeje, Robin Cornelissen, et al.. (2017). Autologous Dendritic Cells Pulsed with Allogeneic Tumor Cell Lysate in Mesothelioma: From Mouse to Human. Clinical Cancer Research. 24(4). 766–776. 71 indexed citations

Kunert, André, Markus Chmielewski, Rebecca Wijers, et al.. (2017). Intra-tumoral production of IL18, but not IL12, by TCR-engineered T cells is non-toxic and counteracts immune evasion of solid tumors. OncoImmunology. 7(1). e1378842–e1378842. 78 indexed citations

Kunert, André, et al.. (2017). T-cell Receptors for Clinical Therapy: In Vitro Assessment of Toxicity Risk. Clinical Cancer Research. 23(20). 6012–6020. 32 indexed citations

10.

Kunert, André, Mandy van Brakel, Pierre G. Coulie, et al.. (2016). MAGE-C2–Specific TCRs Combined with Epigenetic Drug-Enhanced Antigenicity Yield Robust and Tumor-Selective T Cell Responses. The Journal of Immunology. 197(6). 2541–2552. 24 indexed citations

11.

Klaver, Yarne, André Kunert, Stefan Sleijfer, Reno Debets, & C. B. H. W. Lamers. (2015). Adoptive T-cell Therapy: A Need for Standard Immune Monitoring. Immunotherapy. 7(5). 513–533. 16 indexed citations

12.

Kunert, André, Trudy Straetemans, Coen Govers, et al.. (2013). TCR-Engineered T Cells Meet New Challenges to Treat Solid Tumors: Choice of Antigen, T Cell Fitness, and Sensitization of Tumor Milieu. Frontiers in Immunology. 4. 363–363. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact